NCT03980509View on ClinicalTrials.gov

"A Window Trial on Curcumin for Invasive Breast Cancer Primary Tumors"

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

January 29, 2020

Primary Completion Date

March 24, 2022

Study Completion Date

March 24, 2023

Conditions
Breast Cancer
Interventions
DRUG

Curcumin

Curcumin is an extract from turmeric

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT03980509 - "A Window Trial on Curcumin for Invasive Breast Cancer Primary Tumors" | Biotech Hunter | Biotech Hunter